As of now, when it comes to protection against prevalent diseases, Dr Gagandeep Kang, a renowned virologist, points that our ...

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

The U.S. vaccine policy landscape is broader and changing more rapidly than at any point in its modern history, and those ...

Shares in vaccine ... causes invasive pneumococcal disease, the company said. Vaxcyte’s shot covers an additional 11 strains than Prevnar 20, for a total of 31. The company plans to advance its ...

Pneumococcal vaccination may reduce the risk for pneumonia-related morbidity and mortality among patients with immune-mediated inflammatory diseases.

Public health authorities outline who needs which vaccines, organized by age and other key variables—important information ...

Background: Respiratory syncytial virus (RSV) vaccines could reduce disease burden and costs in older Canadian adults, but vaccination program cost-effectiveness is unknown. We evaluated the ...

With monsoon season increasing infectious disease risks, adult immunization is crucial yet underutilized in India. Low ...

Vaxcyte’s market potential is driven by $13.3B TAM in pneumococcal vaccine market, with potential FDA approval by late 2026 ...

guidelines for children and adolescents vaccine schedules for school attendance. All providers need to be familiar with the immunization requirements for school attendance in the states in which they ...

Vaccine administration practices are based on clinical trials that determine the dose, route and schedule for each vaccine. Professional standards for medication and vaccine administration, and ...